Author： Carson Patricia A Forchheimer Daniel Draper David N
Publisher： Future Science
ISSN： 2046-8954
Source： Pharmaceutical Patent Analyst, Vol.2, Iss.4, 2013-07, pp. : 467-479
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The duty of disclosure in the post-Therasense landscape
Pharmaceutical Patent Analyst, Vol. 2, Iss. 2, 2013-03 ,pp. :
Access to resources
Recommend
By Winckler T.
Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 7, 2013-07 ,pp. :
Caspase Inhibitors: A Pharmaceutical Industry Perspective
Current Topics in Medicinal Chemistry, Vol. 5, Iss. 16, 2005-12 ,pp. :
Issues in the Conduct of Therapeutic Trials in Palliative Care: An Australian Perspective
By Maddocks I.
Drugs & Aging, Vol. 19, Iss. 7, 2002-01 ,pp. :
Challenges in Pediatric Drug Development: A Pharmaceutical Industry Perspective
By Rose Klaus
Pediatric Drugs, Vol. 11, Iss. 1, 2009-01 ,pp. :